Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Ryoji Kato"'
Autor:
Tsutomu Iwasa, Junji Tsurutani, Satomi Watanabe, Ryoji Kato, Yutaka Mizuno, Yasuyuki Kojima, Tsutomu Takashima, Nobuki Matsunami, Takashi Morimoto, Jun Yamamura, Shoichiro Ohtani, Yuko Tanabe, Tetsuhiro Yoshinami, Toshimi Takano, Yoshifumi Komoike, Kazuhiko Nakagawa
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background We previously reported the synergistic effect of S-1 and eribulin in preclinical models. In addition, our phase I study revealed the recommended dose for the phase II study of the combination therapy in advanced breast cancer (ABC
Externí odkaz:
https://doaj.org/article/0a03588daea444e08474b844baa4c3b0
Autor:
Hitomi Sakai, Hisato Kawakami, Takeshi Teramura, Yuta Onodera, Elizabeth Somers, Keiji Furuuchi, Toshimitsu Uenaka, Ryoji Kato, Kazuhiko Nakagawa
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 6, Pp n/a-n/a (2021)
Abstract Background The main function of folate receptor α (FOLRα) has been considered to mediate intracellular folate uptake and induce tumor cell proliferation. Given the broad spectrum of expression among malignant tumors, including gastric canc
Externí odkaz:
https://doaj.org/article/123305652e1b46c1a6de16796002c111
Autor:
Yaeko Yokoshima, Masahiko Sumitani, Daisuke Nishizawa, Makoto Nagashima, Kazutaka Ikeda, Ryoji Kato, Jun Hozumi, Hiroaki Abe, Kenji Azuma, Rikuhei Tsuchida, Yoshitsugu Yamada, Japanese TR‐Cancer Pain Research Group
Publikováno v:
Neuropsychopharmacology Reports, Vol 38, Iss 4, Pp 175-181 (2018)
Abstract Aim Cancer pain impairs not only physical functions but also social functions and roles. Consequently, the overall health‐related quality of life of patients with cancer pain deteriorates. Opioid analgesics are recommended for treating mod
Externí odkaz:
https://doaj.org/article/239702f437894a6397ce460e3e2f3701
Autor:
Ryoji Kato, Hidetoshi Hayashi, Eriko Miyawaki, Junichi Shimizu, Tomohiro Ozaki, Daichi Fujimoto, Ryo Toyozawa, Atsushi Nakamura, Toshiyuki Kozuki, Kentaro Tanaka, Shunsuke Teraoka, Kazuhiro Usui, Kazumi Nishino, Osamu Hataji, Keiichi Ota, Noriyuki Ebi, Sho Saeki, Yuki Akazawa, Motoyasu Okuno, Kazuhiko Nakagawa
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
BackgroundStudies have suggested that chemotherapy after immune checkpoint inhibitors may confer an improved response for non–small cell lung cancer (NSCLC). However, potential selection bias in such studies has not been addressed. We therefore app
Externí odkaz:
https://doaj.org/article/a1e05f97528e462ca8d6640b3c0bea4b
Autor:
Daichi Fujimoto, Ryoji Kato, Takeshi Morimoto, Ryoko Shimizu, Yuki Sato, Mariko Kogo, Jiro Ito, Shunsuke Teraoka, Kazuma Nagata, Atsushi Nakagawa, Kojiro Otsuka, Keisuke Tomii
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0168465 (2016)
Data on characteristics, outcomes, and prognosis of advanced non-small-cell lung cancer (NSCLC) patients who develop pneumonitis during systemic anti-cancer therapy (pneumonitis) are currently lacking.We conducted a retrospective cohort study of 910
Externí odkaz:
https://doaj.org/article/d84ceba2285440fbbaaceb0a6bea8b57
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Masaaki Miyazawa, Kenji Hirotani, Michiko Yamato, Hiroyasu Kaneda, Yoshikazu Hasegawa, Keita Kudo, Takafumi Okabe, Yasutaka Chiba, Kazuko Sakai, Osamu Maenishi, Sigeki Kato, Masayuki Takeda, Hidetoshi Hayashi, Kaoru Tanaka, Takayuki Takahama, Naoki Takegawa, Ryoji Kato, Hitomi Sakai, Shiki Takamura, Koji Haratani, Kimio Yonesaka
Cox proportional hazard model for PFS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505dd07e89ca0903d27a29cfc2bd0676
https://doi.org/10.1158/1078-0432.22464515.v1
https://doi.org/10.1158/1078-0432.22464515.v1
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Masaaki Miyazawa, Kenji Hirotani, Michiko Yamato, Hiroyasu Kaneda, Yoshikazu Hasegawa, Keita Kudo, Takafumi Okabe, Yasutaka Chiba, Kazuko Sakai, Osamu Maenishi, Sigeki Kato, Masayuki Takeda, Hidetoshi Hayashi, Kaoru Tanaka, Takayuki Takahama, Naoki Takegawa, Ryoji Kato, Hitomi Sakai, Shiki Takamura, Koji Haratani, Kimio Yonesaka
Effect of using a combination of targeting B7-H3 and PD-L1 on body weight in the murine tumor model
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d23b233794e7c93aca35e20ccea76fe
https://doi.org/10.1158/1078-0432.22464524
https://doi.org/10.1158/1078-0432.22464524
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Kazuko Sakai, Hidetoshi Hayashi, Hisato Kawakami, Junko Tanizaki, Koji Haratani, Hitomi Sakai, Ryoji Kato, Toshiyuki Takehara, Takeshi Teramura, Kimio Yonesaka, Shinichiro Suzuki
Purpose:Treatment with KRASG12C inhibitors such as sotorasib can produce substantial regression of tumors in some patients with non–small cell lung cancer (NSCLC). These patients require alternative treatment after acquiring resistance to the inhib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::515508c588c2e1caeb4109c863e2de8b
https://doi.org/10.1158/1078-0432.c.6530453.v1
https://doi.org/10.1158/1078-0432.c.6530453.v1
Autor:
Kazuhiko Nakagawa, Kazuto Nishio, Masaaki Miyazawa, Kenji Hirotani, Michiko Yamato, Hiroyasu Kaneda, Yoshikazu Hasegawa, Keita Kudo, Takafumi Okabe, Yasutaka Chiba, Kazuko Sakai, Osamu Maenishi, Sigeki Kato, Masayuki Takeda, Hidetoshi Hayashi, Kaoru Tanaka, Takayuki Takahama, Naoki Takegawa, Ryoji Kato, Hitomi Sakai, Shiki Takamura, Koji Haratani, Kimio Yonesaka
Purpose: Anti-programmed-death-1 (PD-1) immunotherapy improves survival in non–small cell lung cancer (NSCLC), but some cases are refractory to treatment, thereby requiring alternative strategies. B7-H3, an immune-checkpoint molecule, is expressed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95980b3d3cae0019d5b82f348c03f737
https://doi.org/10.1158/1078-0432.c.6525734
https://doi.org/10.1158/1078-0432.c.6525734
Autor:
Kazuhiko Nakagawa, Akihiko Ito, Tadashi Ishida, Takashi Ogura, Masayuki Takeda, Kaoru Tanaka, Junko Tanizaki, Ryoji Kato, Yasutaka Chiba, Yasushi Fukuda, Toshihide Yokoyama, Takashi Niwa, Shuta Tomida, Shigeki Shimizu, Hidetoshi Hayashi, Koji Haratani, Kohsuke Isomoto
Supplementary_Figurelegends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54f66be4dad9a86c027711599d764e63
https://doi.org/10.1158/1078-0432.22479297.v1
https://doi.org/10.1158/1078-0432.22479297.v1